Baxter Alerted FDA To Problem Before Receiving Warning Letter, Firm Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The letter details problems related to Baxter's use of albumin in the manufacturing of its Isolex 300i Magnetic Cell Selection System, a device/biologic regulated as a Class III device.